Mounjaro 2.5mg/0.5ml is the starting dose in the Mounjaro treatment plan for type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps control blood sugar and supports metabolic balance. This dose allows the body to adjust gradually to the medication. Each pack includes 4 pre-filled pens for convenient weekly subcutaneous injections. Must be used under a healthcare provider's supervision.